Photo of Susan Charman

View Scopus Profile

Susan Charman

Professor

 https://orcid.org/0000-0003-1753-8213
1991 …2020
If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Drug Discovery and Development. Drug Metabolism and Pharmacokinetics.  Drug Delivery. Drug Discovery for Neglected and Tropical Diseases.

Biography

Susan Charman is Director of the Centre for Drug Candidate Optimisation, and Professor at the Monash Institute of Pharmaceutical Sciences. Her research is focussed on ADME-informed drug candidate optimisation to translate basic biology and chemistry discoveries into new drug candidates. She is particularly interested in the lead optimisation and progression of novel drug candidates for the treatment of neglected and tropical infectious diseases.

Keywords

  • Drug development
  • Drug discovery
  • Pharmaceutics
  • Pharmacokinetics
  • Drug Metabolism

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2020

Targeting trypanosomatid deoxyhypusine synthase

Phillips, M., Charman, S. A., DeBrabender, J. & Posner, B.

National Institutes of Health (NIH US)

5/12/18 → 30/11/19

Project: Research

Novel peptide inhibitors of the potassium voltage-gated channel Kv1.3 as therapeutics for autoimmune diseases

Norton, R. S. & Charman, S. A.

23/10/18 → 23/10/19

Project: Research

Male contraception through pharmacological blockade of sperm transport

Ventura, S., Baell, J. B., Charman, S. A. & Sexton, P.

Male Contraceptive Initiative

1/08/18 → 31/05/20

Project: Research

Novel TB Drug Candidates via the Inhibition of Lipid I Biosynthesis

Payne, R., Britton, W., Crick, D., Charman, S. A. & West, N.

National Health & Medical Research Council (NHMRC)

1/01/18 → 31/12/20

Project: Research

Defining the mechanisms of action for ozonide antimalarials

Creek, D. J., Charman, S. A. & Edgington-Mitchell, L.

National Health & Medical Research Council (NHMRC)

1/01/17 → 31/12/19

Project: Research

Research Output 1991 2018

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"

Brunschwig, C., Lawrence, N., Taylor, D., Abay, E., Njoroge, M., Basarab, G. S., Le Manach, C., Paquet, T., Gonzàlez Cabrera, D., Nchinda, A. T., de Kock, C., Wiesner, L., Denti, P., Waterson, D., Blasco, B., Leroy, D., Witty, M. J., Donini, C., Duffy, J., Wittlin, S. & 28 othersWhite, K. L., Charman, S. A., Jiménez-Díaz, M. B., Angulo-Barturen, I., Herreros, E., Gamo, F. J., Rochford, R., Mancama, D., Coetzer, T. L., van der Watt, M. E., Reader, J., Birkholtz, L. M., Marsh, K. C., Solapure, S. M., Burke, J. E., McPhail, J. A., Vanaerschot, M., Fidock, D. A., Fish, P. V., Siegl, P., Smith, D. A., Wirjanata, G., Noviyanti, R., Price, R. N., Marfurt, J., Silue, K. D., Street, L. J. & Chibale, K., 1 Nov 2018, In : Antimicrobial Agents and Chemotherapy. 62, 11

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Open Access
File

Novel Toxoplasma gondii inhibitor chemotypes

Sanford, A. G., Schulze, T. T., Potluri, L. P., Hemsley, R. M., Larson, J. J., Judge, A. K., Zach, S. J., Wang, X., Charman, S. A., Vennerstrom, J. L. & Davis, P. H., 1 Apr 2018, In : Parasitology International. 67, 2, p. 107-111 5 p.

Research output: Contribution to journal › Article › Research › peer-review

Parasite-mediated degradation of synthetic ozonide antimalarials impacts in vitro antimalarial activity

Giannangelo, C., Stingelin, L., Yang, T., Tilley, L., Charman, S. A. & Creek, D. J., 1 Mar 2018, In : Antimicrobial Agents and Chemotherapy. 62, 3, 14 p., e01566-17.

Research output: Contribution to journal › Article › Research › peer-review

Progress in antischistosomal N,N′-diaryl urea SAR

Wu, J., Wang, C., Leas, D., Vargas, M., White, K. L., Shackleford, D. M., Chen, G., Sanford, A. G., Hemsley, R. M., Davis, P. H., Dong, Y., Charman, S. A., Keiser, J. & Vennerstrom, J. L., 1 Feb 2018, In : Bioorganic and Medicinal Chemistry Letters. 28, 3, p. 244-248 5 p.

Research output: Contribution to journal › Article › Research › peer-review

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

Paquet, T., Le Manach, C., Cabrera, D. G., Younis, Y., Henrich, P. P., Abraham, T. S., Lee, M. C. S., Basak, R., Ghidelli-Disse, S., Lafuente-Monasterio, M. J., Bantscheff, M., Ruecker, A., Blagborough, A. M., Zakutansky, S. E., Zeeman, A-M., White, K. L., Shackleford, D. M., Mannila, J., Morizzi, J., Scheurer, C. & 1 othersCharman, S. A., 26 Apr 2017, In : Science Translational Medicine. 9, 387, 14 p., eaad9735.

Research output: Contribution to journal › Article › Research › peer-review